Price $481.52 |
Market Cap
438.49B
|
Sector Health Care |
Div. Growth
14.30%
|
|
P/E
22.3
|
P/B
5.68
|
P/S
1.36
|
Dividend %
1.40%
|
|
P/CF
229.8
|
P/FCF
25.8
|
Op. Cash Flow
26.21M
|
FCF
18.3
|
|
Op. Margin
8.80%
|
Net Margin
6.20%
|
ROE
27.00%
|
ROI
16.80%
|
|
ROA
8.60%
|
EPS Growth
17.20%
|
Current Ratio
-
|
Debt/Equity
70.10%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Interpace Biosciences Inc (IDXG) | $2.52 | - | - | 4.8M | Strong Buy |
| Akebia Therapeutics Inc (AKBA) | $1.13 | - | - | 103.8M | Strong Buy |
| Arcturus Therapeutics Holdings (ARCT) | $27.17 | - | - | 548.1M | Strong Buy |
| KORU Medical Systems Inc (KRMD) | $3.70 | - | - | 191M | Strong Buy |
| Teva Pharmaceutical Industries (TEVA) | $7.45 | - | - | 9.93B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
